WatchGov

119th Congress

H.R. 586

Vietnam Veterans Liver Fluke Cancer Study Act

  1. Introduced
  2. In committee
  3. Passed House
  4. Passed Senate
  5. To President
  6. Became law
Sponsor
Nick LaLota(R-NY)
Introduced
Jan 21, 2025
Policy area
Armed Forces and National Security
Committees
House Committee on Veterans' Affairs; Senate Committee on Veterans' Affairs
Official text
Referred in Senate · Congress.gov page

Cosponsors (8)

Original cosponsors (5)

Added later (3)

Summary

Summary by the Congressional Research Service· describes the “Introduced in House” version

Vietnam Veterans Liver Fluke Cancer Study Act This bill requires the Department of Veterans Affairs (VA) to conduct an epidemiological study and report on the prevalence of cholangiocarcinoma (bile duct cancer) in veterans who served in the Vietnam theater of operations during the Vietnam era. The study must identify the rate of incidence of cholangiocarcinoma in such veterans and in U.S. residents. The bill also requires the VA to track and report on the prevalence of cholangiocarcinoma using the Veterans Affairs Central Cancer Registry. Additionally, the VA must periodically submit follow-up reports to Congress regarding the epidemiological study and information collected from the cancer registry regarding the prevalence of bile duct cancer.

Roll-call votes

DateVoteResultYour members
Apr 7, 2025
House #89
On Motion to Suspend the Rules and Pass, as Amended: Vietnam Veterans Liver Fluke Cancer Study ActPassedSet your home to see

Actions